Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsMulti-cellular hepatocellular carcinoma (HCC) organoid models were established which contained various types of stromal cells, such as hepatic stellate cells, fibroblasts, and endothelial cells together with HCC cells.
[Hepatology]
6445212 HBFYVI5E items 1 apa 0 default asc 1 163286 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-719378dd0d6d957e71105cbb11b3ed25%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22HBFYVI5E%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cho%20et%20al.%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECho%2C%20K.%2C%20Ro%2C%20S.%20W.%2C%20Lee%2C%20H.%20W.%2C%20Moon%2C%20H.%2C%20Han%2C%20S.%2C%20Kim%2C%20H.%20R.%2C%20Ahn%2C%20S.%20H.%2C%20Park%2C%20J.%20Y.%2C%20%26amp%3B%20Kim%2C%20D.%20Y.%20%28n.d.%29.%20YAP%5C%2FTAZ%20suppress%20drug%20penetration%20into%20hepatocellular%20carcinoma%20via%20stromal%20activation.%20%3Ci%3EHepatology%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fhep.32000%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fhep.32000%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DHBFYVI5E%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22YAP%5C%2FTAZ%20suppress%20drug%20penetration%20into%20hepatocellular%20carcinoma%20via%20stromal%20activation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyungjoo%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20Weonsang%22%2C%22lastName%22%3A%22Ro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hye%20Won%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyuk%22%2C%22lastName%22%3A%22Moon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sojung%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hye%20Rim%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sang%20Hoon%22%2C%22lastName%22%3A%22Ahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Yong%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Do%20Young%22%2C%22lastName%22%3A%22Kim%22%7D%5D%2C%22abstractNote%22%3A%22Backgroud%20%26%20Aims%20Hepatocellular%20carcinoma%20%28HCC%29%20is%20the%20most%20predominant%20type%20of%20liver%20cancer%20affecting%20800%2C000%20people%20globally%20each%20year.%20Various%20small-molecule%20compounds%20targeting%20diverse%20oncogenic%20signaling%20pathways%20have%20been%20tested%20for%20HCC%20patients%20and%20clinical%20outcomes%20were%20not%20satisfactory.%20In%20this%20study%2C%20we%20investigated%20molecular%20signaling%20that%20determines%20the%20efficiency%20of%20drug%20delivery%20into%20HCC.%20Approach%20%26%20Results%20Hydrodynamics-based%20transfection%20%28HT%29%20was%20performed%20to%20develop%20mouse%20models%20for%20HCC%20induced%20by%20various%20oncogenes.%20Mice%20bearing%20liver%20cancer%20were%20treated%20with%20verteporfin%20at%205%20weeks%20post%20HT.%20Multi-cellular%20HCC%20organoid%20%28MCHO%29%20models%20were%20established%20which%20contained%20various%20types%20of%20stromal%20cells%2C%20such%20as%20hepatic%20stellate%20cells%2C%20fibroblasts%2C%20and%20endothelial%20cells%20together%20with%20HCC%20cells.%20Tumor%20organoids%20were%20treated%20with%20verteporfin%20and%20distributions%20of%20the%20drug%20in%20the%20organoids%20were%20assessed%20using%20fluorescence%20microscopy.%20Murine%20HCC%20models%20developed%20by%20HT%20methods%20showed%20that%20a%20high%20YAP%5C%2FTAZ%20activity%20in%20HCC%20cells%20impaired%20verteporfin%20penetration%20into%20the%20cancer.%20Activation%20of%20tumor%20stroma%20was%20observed%20in%20HCC%20with%20a%20high%20YAP%5C%2FTAZ%20activity.%20Consistent%20with%20the%20findings%20in%20the%20in%20vivo%20models%20of%20HCC%2C%20MCHOs%20with%20activated%20YAP%5C%2FTAZ%20signaling%20showed%20stromal%20activation%20and%20impaired%20penetration%20of%20verteporfin%20into%20the%20tumor%20organoids.%20Inhibition%20of%20YAP%5C%2FTAZ%20transcriptional%20activity%20in%20HCC%20cells%20significantly%20increased%20drug%20penetration%20into%20the%20MCHO.%20Conclusions%20Drug%20delivery%20into%20liver%20cancer%20is%20impaired%20by%20YAP%5C%2FTAZ%20signaling%20in%20tumor%20cells%20and%20subsequent%20activation%20of%20stroma%20by%20the%20signaling.%20Disrupting%20or%20targeting%20activated%20tumor%20stroma%20might%20improve%20drug%20delivery%20into%20HCC%20with%20an%20elevated%20YAP%5C%2FTAZ%20activity.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Fhep.32000%22%2C%22ISSN%22%3A%221527-3350%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Faasldpubs.onlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fhep.32000%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-10T18%3A07%3A47Z%22%7D%7D%5D%7D
Cho, K., Ro, S. W., Lee, H. W., Moon, H., Han, S., Kim, H. R., Ahn, S. H., Park, J. Y., & Kim, D. Y. (n.d.). YAP/TAZ suppress drug penetration into hepatocellular carcinoma via stromal activation. Hepatology, n/a(n/a). https://doi.org/10.1002/hep.32000 Cite
